HEALTH

Boosting Medication Use and Ending Delays in Heart Disease Treatment: A Challenge for the Middle East

Middle EastWed Jan 22 2025
In the Middle East, three big health problems – high blood pressure, unhealthy cholesterol levels, and type 2 diabetes – are on the rise. Worryingly, these conditions aren't well-controlled. One of the main reasons is that people often don't stick to their treatment plans, a problem known as therapeutic non-adherence, and doctors can be slow to adjust treatments, called therapeutic inertia. To tackle these issues, healthcare experts met at the 2024 EVIDENT Summit. They shared some smart ways to improve how people follow their treatment plans and to help doctors make better decisions faster. Some of the best ideas include using combination pills early on, teaching patients about their health, and having a team of different healthcare providers work together. The goal is to ease the heavy toll of heart disease in the region. Patients in the Middle East frequently face challenges with sticking to their medication plans. This can be due to several reasons, including the complexity of their treatment regimens and a lack of understanding about their health conditions. Simplifying treatment plans can make a big difference. Using single-pill combinations that combine multiple medications into one can help patients stay on track. These combinations can be started right away, which is key to keeping diseases under control. Education plays a crucial role in helping patients understand their conditions and the importance of staying with their treatment plans. When patients are well-informed, they are more likely to adhere to their medications. Healthcare providers can organize educational sessions and use easy-to-understand materials to ensure patients grasp their health needs. A team-based approach can also significantly improve the management of cardiometabolic diseases. Having pharmacists, nurses, and doctors work together ensures that patients receive comprehensive care. This collaborative effort can lead to better health outcomes. Healthcare providers and stakeholders are now challenging themselves to put these solutions into action within health systems across the Middle East. Their aim is to achieve significant improvements in cardiovascular health outcomes.

questions

    Are there hidden environmental factors in the Middle East that contribute to the high prevalence of cardiometabolic diseases?
    What are the most effective educational initiatives for improving therapeutic adherence among patients with cardiometabolic diseases?
    How can we measure the success of educational initiatives in improving therapeutic adherence in a reliable and standardized manner?

actions